Cholestyramine Impairs Absorption of Multiple Medications Through Binding in the GI Tract
Cholestyramine significantly reduces the absorption of numerous medications, and all other drugs should be administered at least 1 hour before or 4-6 hours after cholestyramine to avoid clinically significant interactions. 1
Medications with Documented Reduced Absorption
Cardiovascular Medications
- Warfarin: Cholestyramine interferes with intestinal absorption and enterohepatic circulation of warfarin, requiring dose separation and close INR monitoring 2, 3
- Digoxin: Significant binding occurs; dose separation is essential 2, 1
- Thiazide diuretics (e.g., hydrochlorothiazide): Reduced absorption documented 2, 1
- Furosemide: Impaired absorption when co-administered 2
- Propranolol: Binding reduces bioavailability 1
Endocrine Medications
- Thyroid preparations and levothyroxine: Cholestyramine substantially reduces absorption; patients may require increased TSH monitoring and dose adjustments 2, 4, 1
- Estrogens and progestins (including oral contraceptives): Reduced absorption compromises contraceptive efficacy 2, 4, 1
Antibiotics
Neuropsychiatric Medications
- Phenobarbital: Impaired absorption 2, 1
- Phenytoin: Reduced absorption; may require dose adjustments 4
- Imipramine: 23% decrease in plasma levels documented in clinical study 5
- Valproic acid: 14% reduction in AUC with concurrent administration; staggering doses by 3 hours reduces interaction 6
Other Medications
- Mycophenolic acid: Documented interaction 2
- Phenylbutazone: Reduced absorption 2, 1
- Cyclosporine: Known to have decreased absorption 4
- Olmesartan: Documented interaction 4
- Sulfonylureas (e.g., glyburide): Reduced absorption 4
- Troglitazone: 71% reduction in AUC with concurrent administration 7
- Cerivastatin: 21% decrease in bioavailability with concurrent dosing 8
Fat-Soluble Vitamins and Nutrients
- Vitamins A, D, E, and K: Cholestyramine interferes with fat absorption, reducing fat-soluble vitamin absorption 2, 1
- Folic acid: Long-term use associated with reduced folate levels 2
- Oral phosphate supplements: Interference documented 1
Critical Dosing Strategy
The standard recommendation is to administer all other medications at least 1 hour before or 4-6 hours after cholestyramine. 2, 1 However, some guidelines suggest a 3-hour window may be adequate based on gastric emptying studies 2.
Special Considerations
For warfarin patients: Monitor INR frequently during cholestyramine initiation and periodically thereafter, as the interaction involves both absorption interference and disruption of enterohepatic circulation 4, 3, 1
For thyroid replacement: Increased TSH monitoring is essential, as cholestyramine can significantly reduce levothyroxine absorption 4
For oral contraceptives: Counsel patients about potential contraceptive failure and consider alternative contraception methods 4
For digitalis: The discontinuation of cholestyramine could pose a hazard if digitalis has been titrated to maintenance levels while taking cholestyramine, as absorption will suddenly increase 1
Mechanism of Interaction
Cholestyramine is a positively-charged, non-absorbable anion exchange resin that binds drugs in the intestinal lumen, forming insoluble complexes that are excreted in feces 1, 9. The interaction is particularly significant for drugs undergoing enterohepatic circulation, as cholestyramine continuously removes these drugs from the GI tract 1.
Common Pitfall
The most critical error is failing to separate medication administration times. Even with proper spacing, some interactions (particularly with warfarin and fat-soluble vitamins) cannot be completely avoided due to enterohepatic circulation, requiring ongoing monitoring and potential supplementation 1.